Immunohistochemistry (IHC) Market By Product (Reagents (Chromogenic Substrates), Antibodies, and Kits), By Application (Research, Diagnostics (Cancer, Infectious), and Forensic), By End User (Diagnostic Laboratories, Hospitals, and Academic), By Region (North America, Latin America, Europe, Middle East, Asia Pacific, South Africa, and Rest of the World) – Market Size, Share, Growth, and Company Profiles Report 2020-2025

Published: April 2021 | Report ID: 092 | Pages: 16 | Available Formats: PDF, PPT | Author: Ravi

Immunohistochemistry (IHC) Market Overview:

Immunohistochemistry (IHC) Market size valued at 1.5 billion in 2019, and it is expected to reach USD 2.6 billion by the end of 2025, with growth at a CAGR of 6.7% during the forecast period 2020-2025. Immunohistochemistry is the utmost collective application of immune staining. Immunohistochemistry has the procedure of collectively finding the antigens in human cells.

Immunohistochemistry is involved to aid diagnose diseases, such as cancer. It may furthermore be used to benefit tell the variance between dissimilar types of cancer. The increase in the existence of cancer can be credited to the growing geriatric as well as the total population.

Elements such as the overview of technically progressive immunohistochemistry results, growing drug discovery and expansion actions, and increasing occurrence of chronic diseases are predictable to considerably fuel immunohistochemistry (IHC) market growth throughout the forecast period 2020-2025. Growing product sanctions and the summary of technically advanced immunohistochemistry clarifications for disease analysis are further fueling the growth of the Immunohistochemistry (IHC) Market.

Immunohistochemistry (IHC) Market Report Statistics:



Market Size Available

2019 – 2025

Base Year


Forecast Period

2020 – 2025

Segments Covered

By Product, By Application, By End User, and By Region

Countries Covered

USA, Canada, Brazil, Mexico, Argentina, Germany, the United Kingdom, Spain, Italy, London, UAE, KSA Qatar, South Africa, India, China, Japan, Singapore, Australia, Malaysia, Hang Kong, Korea, and the rest of the countries.

Download Sample Report for More Information

Immunohistochemistry (IHC) Market Segmentation Overview:

The global Immunohistochemistry (IHC) Market is segmented based on Product, Based on Application, and Based on End-user.

By Product, the segment is sub-divided into Reagents (Chromogenic Substrates), Antibodies, and Kits. By Application is further classified into Research, Diagnostics (Cancer, Infectious), and Forensic. By End User into Diagnostic Laboratories, Hospitals, and Academic.

Immunohistochemistry (IHC) Market Regions and Country Classification:

Immunohistochemistry (IHC) Market Geographical Classification into North America into the USA, Canada, Latin America into Brazil, Argentina, Mexico, Europe into UK, Germany, Spain, France, London, Italy, and the rest of the European countries. The Middle East and Africa into UAE, KSA, Qatar, and South Africa, Asia Pacific into India, China, Japan, Malaysia, Singapore, Australia, and the Rest of the APAC countries

Immunohistochemistry (IHC) Market Regional Insights:

North America Immunohistochemistry (IHC) Market accounted for the major share of the immunohistochemistry market in 2019. The development in this regional market can be accredited to the existence of major companies operating in the immunohistochemistry market in the US, increasing incidence of cancer and infectious diseases, and the growing implementation of companion diagnostic analysis equipment.

North America region has a well-known healthcare structure, which has controlled an upsurge in the implementation of immunohistochemistry devices in diagnostic centers and laboratories. The Asia Pacific immunohistochemistry market is estimated to reveal the uppermost growth owing to fast economic growth in countries such as India, China, Singapore, and South Korea.

Immunohistochemistry (IHC) Market Major Companies Profiled in the market:

The Major Key Companies covered in the market report are; Agilent Technologies, Inc. F. Hoffmann-La Roche Ltd, Merck KGaA, Biocare Medical, LLC., PHC Holding Corporation, and Danaher Corporation.

Immunohistochemistry (IHC) Market Segmentation:

By Product

  • Reagents
    • Chromogenic Substrates
  • Antibodies
  • Kits

By Application

  • Research
  • Diagnostics
    • Cancer
    • Infectious
  • Forensic

By End-User

  • Diagnostic Laboratories
  • Hospitals
  • Academic

Geographical Classification:

  1. North America
  2. Latin America
  3. Middle East and Africa
  4. Europe
  5. Asia Pacific
  6. Rest of the World

Major Key Players:

  1. Agilent Technologies, Inc
  2. Hoffmann-La Roche Ltd
  3. Merck KGaA
  4. Biocare Medical, LLC.
  5. PHC Holding Corporation
  6. Danaher Corporation

Note: Information provided by you stored on our secure servers. We Protect Your Privacy.

1. Preface

                1.1 Market Definition and Scope

                1.2 Base Currency, Base Year and Forecast Periods

                1.3 Key Research Objectives

                1.4 Research Highlights

2. General Study Assumptions

3. Research Methodology

                3.1 Introduction

                3.2 Secondary Research

                3.3 Primary Research

                3.4 Analysis Design

                3.5 Study Timeline

4. Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

                4.4 Market Trends

5. Supply Chain Analysis

6. Company Strategy Analysis

                6.1 Merger and Acquisition Analysis

                6.2 Agreements, Collaborations and Joint Ventures

                6.3 Regional Presence

                6.4 New Product Launches

7. Market Outlook

                7.1 Technological Advancement

                7.2 Pricing Analysis

                7.3 Epidemiology

                7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)

8. Market Segmentation

                8.1 Overview

                8.2 Global Immunohistochemistry (IHC) Market, By Product, forecast year 2020-2025

                                8.2.1 Reagents

                                       Chromogenic Substrates

                                8.2.2 Antibodies

                                8.2.3 Kits

                                8.2.4 Market Size Estimations & Forecasts (2020-2025)

                                8.2.5 Y-o-Y Growth Analysis

                                8.2.6 Market Investment Opportunities Analysis

                8.3 Global Immunohistochemistry (IHC) Market, By Application, forecast year 2020-2025

                                8.3.1 Research

                                8.3.2 Diagnostics



                                8.3.3 Forensic

                                8.3.4 Market Size Estimations & Forecasts (2020-2025)

                                8.3.5 Y-o-Y Growth Analysis

                                8.3.6 Market Investment Opportunities Analysis

                8.3 Global Immunohistochemistry (IHC) Market, By End User, forecast year 2020-2025

                                8.3.1 Diagnostic Laboratories

                                8.3.2 Hospitals

                                8.3.3 Academic

                                8.3.4 Market Size Estimations & Forecasts (2020-2025)

                                8.3.5 Y-o-Y Growth Analysis

                                8.3.6 Market Investment Opportunities Analysis

9. Market Regional and Country Analysis, Forecast 2020-2025

                9.1 Overview

                9.2 Regional Trends

                9.3 Impact Analysis

                9.4 Key Findings

                9.5 Global Immunohistochemistry (IHC) Market,  by Region, 2020-2025

                                9.5.1 By Product

                                9.5.2 By Application

                                9.5.3 End User

10. Competitive Landscape Analysis

                10.1 Market Player

                                10.1.1 Company Revenue

                                10.1.2 Business unit

                                10.1.3 Product Mapping

                                10.1.4 Geographical Locations

                10.2 Company Share Analysis

11. Strategic Analysis

                11.1 PESTLE analysis

                11.2 Porter’s Five analysis

                                11.2.1 Bargaining Power of Suppliers

                                11.2.2 Bargaining Power of Consumers

                                11.2.3 Threat of New Entrants

                                11.2.4 Threat of Substitute Products and Services

                                11.2.5 Competitive Rivalry within the Industry

12. Company Profiles

                12.1 Agilent Technologies, Inc

                                12.1.1 Overview

                                12.1.2 Product Portfolio

                                12.1.3 Financial Details

                                12.1.4 SWOT Analysis

                                12.1.5 Market Strategies

                12.2 F. Hoffmann-La Roche Ltd

                12.3 Merck KGaA

                12.4 Biocare Medical, LLC

                12.5 PHC Holding Corporation

                12.6 Danaher Corporation

13. Market Guidance

14. Appendix